Phase 4 Comparative Study of Peginterferon alfa-2a vs Peginterferon alfa-2b for Treatment of Chronic Hepatitis C Genotype 4
Phase of Trial: Phase IV
Latest Information Update: 22 Oct 2012
At a glance
- Drugs Peginterferon alfa-2a (Primary) ; Peginterferon alfa-2b (Primary) ; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- 23 Jul 2010 Additional lead trial centre identified as reported by ClinicalTrials.gov.
- 28 Jan 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 02 Mar 2009 Planned end date changed from 1 Oct 2008 to 1 May 2009 as reported by ClinicalTrials.gov.